PREGNANCY and Hydroxyzine


PREGNANCY Symptoms and Causes

So you're going to have a baby! Whether you are pregnant or are planning to get pregnant, you will want to give your baby a healthy start.

You need to have regular visits with your health care provider. These prenatal care visits are very important for your baby and yourself. Some things you might do when you are pregnant could hurt your baby, such as smoking or drinking. Some medicines can also be a problem, even ones that a doctor prescribed. You will need to drink plenty of fluids and eat a healthy diet. You may also be tired and need more rest.

Your body will change as your baby grows during the nine months of your Pregnancy. Don't hesitate to call your health care provider if you think you have a problem or something is bothering or worrying you.

Check out the latest treatments for PREGNANCY

PREGNANCY treatment research studies

Hydroxyzine clinical trials, surveys and public health registries

Find Drug Side Effect reports

Hydroxyzine Side Effects

Completed Suicide (135)
Poisoning (62)
Cardiac Arrest (62)
Respiratory Arrest (57)
Death (29)
Toxicity To Various Agents (21)
Overdose (20)
Cardio-respiratory Arrest (18)
Nausea (17)
Anxiety (17)
Dizziness (17)
Somnolence (16)
Headache (16)
Exposure Via Ingestion (15)
Pyrexia (15)
Suicide Attempt (14)
Fall (14)
Pain In Extremity (13)
Pain (13)
Dyspnoea (13)
Condition Aggravated (12)
Confusional State (12)
Tremor (12)
Pruritus (12)
Abdominal Pain (11)
Depression (11)
Vomiting (11)
Fatigue (11)
Convulsion (10)
Asthenia (10)
Diarrhoea (10)
Feeling Abnormal (10)
Tachycardia (10)
Oedema Peripheral (10)
Injection Site Pain (10)
Balance Disorder (9)
Insomnia (9)
Dermatitis Exfoliative (9)
Syncope (9)
Torsade De Pointes (9)
Paraesthesia (8)
Grand Mal Convulsion (8)
Hypotension (8)
Septic Shock (8)
Urticaria (8)
Malaise (7)
Injury (7)
Pleural Effusion (7)
Psoriasis (7)
Myocardial Infarction (7)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Can you take this medicine with glaucoma

Doctor prescribed prometrium.. I am not sure if I should take it or going for a natural medicine I am starting to feel hot flushes and menospause effects... so I am not sure about taking it. Could you share your experience?

Hello , i just started cipralex a month ago ,but only taking 5 mg, i'm 20 weeks pregnant and so afraid that the medication will harm my babay even though the doctor tried to tell me that it safe but i really need it , i'm so afraid it really will har

Hydroxozine hcl is working great to calm my nerves. But, I'm trying to decide if the joint pain is worth it. I believe I have a tic disorder, not anxiety. I've only had one dr visit and they are treating anxiety. But if I don't take roughly, 1200mg o

I took prometrium to raise my hcg levels during a pregnancy and apparently got pregnant right after I miscarried and the I found out at almost 8 weeks along that I had an ectopic pregnancy that had caused my fallopian tube to rupture. I did research

Nothing really is gonna stop teens from getting pregnant once they have their minds set on getting pregnant.

What positive suggestion that will stop early or teenage pregnancy


<strong></strong><span style='color: #476cb8;'><span style='cursor: pointer;'>34 yrs. old 'Ectopic Pregnancy'<span style='display: none;'> Im a 3

I took centrum for almost one month.and I notice that my menstruation suddenly became abnormal in short AMENNORHEA....until now iam almost 1 month and 3 days delayed and took pregnancy test but the result was

<span style='color: #808080;'><strong>Describe Your Drug exposure during pregnancy from INFLUENZA (SEASONAL) (FLUZONE) 2010 Experience Here:</strong> <span style='color: #000000;'><span style=


As human experience is limited, administration of aripiprazole should be used in pregnancy only if the potential benefit to the mother outweighs the potential risk to the foetus.

As it was given by the doctor to my wife as she had rubella antibody positive in the torch profile, She got alittle bleeding during a month pregnancy.

Can immunoglobulin given during pregnancy harm unborn baby?

Check out the class action law suit against implanon for causing pregnancy when IMPROPERLY implanted, meaning it's your dr's fault

Clomid 50 mgs suffered hot flushes, blurred vision, extreme hunger, pregnancy with down syndrome

PREGNANCY Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Sleep Quality in PREGNANCY and Its Impact on PREGNANCY Outcomes
Conditions: Obstructive Sleep Apnea;   PREGNANCY Induced Hypertension;   High-Risk PREGNANCY;   Restless Leg Syndrome;   Infant, Very Low Birth Weight
Intervention: Other: Polysomnography and ambulatory blood pressure recording
Outcome Measures: Sleep quality in PREGNANCY and its association with PREGNANCY outcomes;   Number of patients who develop PIH and gestational diabetes
2 Recruiting Treatment of Caesarean Scar PREGNANCY
Condition: Caesarean Scar PREGNANCY
Intervention: Procedure: transvaginal resection of PREGNANCY tissue
Outcome Measures: The safety of transvaginal resection of PREGNANCY tissue in the treatment of CSP.;   the effectiveness of transvaginal resection of PREGNANCY tissue in the treatment of CSP.;   Baseline clinical characteristic of patient when diagnosed with CSP;   three year recurrence rate
3 Recruiting The Cymbalta PREGNANCY Registry
Condition: PREGNANCY
Intervention: Drug: duloxetine
Outcome Measures: To estimate the risk of major congenital anomalies among pregnancies exposed to Cymbalta;   To estimate risk of recognized spontaneous abortions, stillbirths, elective terminations, minor congenital anomalies, and any serious adverse PREGNANCY outcomes among pregnancies exposed to Cymbalta and their live births during the first year of life;   To examine any potential impact of Cymbalta use while breastfeeding on the infant during the first year of life;   To compare the risk of major congenital anomalies among pregnancies exposed to Cymbalta to an appropriate comparator(s) such as the Centers for Disease Control and Prevention (CDC) Metropolitan Atlanta Congenital Defects Program (MACDP)
4 Recruiting PREGNANCY Complications in Women With BMI>25 kg/m2 Enrolled in a Healthy Lifestyle and Eating Habits Program
Conditions: Maternal Obesity Complicating PREGNANCY, Birth,or Puerperium;   Gestational Diabetes Mellitus in PREGNANCY, Diet- Controlled;   Exercise Addiction;   High-Risk PREGNANCY;   Dietary Modification
Interventions: Behavioral: Specific Therapeutic Lifestyle Changes program in PREGNANCY;   Behavioral: Dietary and behavioral counselling in PREGNANCY
Outcome Measures: bioimpedance analyzer;   75-g 2-h Oral Glucose Tolerance Test (OGTT);   Blood Pressure assessment;   SenseWear system armband;   Pedometer (Omron Walking Style III HJ-203-EK)
5 Recruiting Personalized Management of Body Weight During PREGNANCY
Condition: Weight Gain During PREGNANCY
Intervention: Behavioral: SmartMoms
Outcome Measures: Proportion of pregnant women who gain more weight during PREGNANCY than is recommended by the Institute of Medicine;   Relationship between weight gain during PREGNANCY, the mother's physical activity and diet on the chance of the mother getting diabetes during PREGNANCY;   Relationship between weight gain during PREGNANCY, the mother's physical activity and diet on the baby's weight at birth;   Relationship between weight gain during PREGNANCY, the mother's physical activity and diet on the mother and baby's body fatness;   Relationship between weight gain during PREGNANCY, the mother's physical activity and diet on how much PREGNANCY weight the mother keeps after she delivers her baby;   Relationship between weight gain during PREGNANCY, the mother's physical activity and diet on how much the baby eats
6 Recruiting PREGNANCY Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian
Condition: Hyperemesis Gravidarum
Interventions: Other: PREGNANCY Unique Questionnaire of Emesis (PUQE);   Other: 24 hours self-reported nutritional intake form
Outcome Measures: PREGNANCY Unique Questionnaire of Emesis (PUQE) score reported by hyperemesis patients versus normal pregnant women;   PREGNANCY Unique Questionnaire of Emesis (PUQE) score in relation to self reported 24 hours nutritional intake registration (estimated caloric intake)in hyperemesis patients versus normal pregnant women
7 Recruiting VIBATIV PREGNANCY Registry
Conditions: PREGNANCY;   Congenital Defects;   Infant, Low Birth Weight
Intervention: Drug: telavancin
Outcome Measures: Outcomes of PREGNANCY in women exposed to VIBATIV at any time during PREGNANCY;   Effect of fetal exposure to VIBATIV on PREGNANCY outcomes;   Fetal/neonatal outcomes;   Infant development and milestones through 12 months of age
8 Recruiting Assessment of Alterations in Immune Function During PREGNANCY and Post Parturition
Conditions: PREGNANCY;   Immune Function
Outcome Measures: Changes in lymphocyte and NK cell populations duringPREGNANCY compared to non-pregnant control samples;   Changes in Cytokine profiles during PREGNANCY compared to non-pregnant control samples;   Functionality of Toll-like receptors and changes in gene expression during PREGNANCY during PREGNANCY comparedto non-pregnant control samples;   Functionality of Toll-like receptors and changes in gene expression during PREGNANCY during PREGNANCY compared to non-pregnant control samples, in a subset of pregnant women;   Changes in lymphocyte and INK cell populations during PREGNANCY compared to non-pregnant control samples, in a subset of pregnant women;   Changes in Cytokine profiles during PREGNANCY compared to non pregnant control samples, in a subset of pregnant women
9 Recruiting Optimal Treatment for Women With a Persisting PREGNANCY of Unknown Location
Conditions: Persistent PREGNANCY of Unknown Location;   Ectopic PREGNANCY
Interventions: Drug: Methotrexate;   Procedure: Uterine Evacuation;   Other: Expectant Management
Outcome Measure: Uneventful clinical resolution of a PREGNANCY of Unknown Location without change from the initial management strategy
10 Recruiting BioThrax® (Anthrax) Vaccine in PREGNANCY Registry
Conditions: PREGNANCY Complications;   PREGNANCY Outcome;   Congenital Abnormalities
Intervention: Biological: Observational Intervention
Outcome Measures: PREGNANCY Outcomes;   Maternal Outcomes;   Infant Outcomes
11 Recruiting Exenatide PREGNANCY Registry - Type 2 Diabetes in PREGNANCY
Conditions: Birth Defects;   Type 2 Diabetes;   Preterm Birth
Outcome Measure: Primary Outcome
12 Recruiting CO-OP Trial: Community-based Outreach on Obesity in PREGNANCY
Conditions: Obesity;   PREGNANCY
Intervention: Behavioral: Dietary counseling. Maintain a food diary.
Outcome Measures: Dietary intervention to prevent excessive maternal weight gain during PREGNANCY;   Difference in complication rates between study and control group;   Differences between birth weights in the study and control groups;   Differences in leptin levels between study and control groups;   Difference in food frequency questionnaire responses between study and control groups;   Is infant birth weight correlated with total gestational weight gain?;   Difference in infant body weight between study and control groups;   Do study subjects use the food diary and bring to visits/subject compliance;   Barriers to healthful eating in study and control groups;   Differences in quality of life between study and control groups;   Differences in onset of lactation postpartum between study and control groups;   Differences in breastfeeding practices between study and control groups
13 Not yet recruiting Prospects for the Prevention of PREGNANCY-induced Hypertension and Preeclampsia Trial
Condition: PREGNANCY Induced Hypertension
Interventions: Drug: Combined aspirin and multinutrient supplement;   Other: Daily text reminder text messages
Outcome Measures: Development of PREGNANCY-induced hypertension (PIH) in PREGNANCY;   Maternal/obstetric outcomes;   Neonatal and infant outcomes;   Number of participants with (severe) adverse events as a measure of safety and tolerability
14 Recruiting An Observational Study of PREGNANCY And PREGNANCY Outcomes in Women With Breast Cancer Treated With Herceptin, Perjeta In Combination With Herceptin, or Kadcyla During PREGNANCY or Within 6 Months Prior To Conception (MotHER)
Conditions: Breast Cancer;   PREGNANCY
Outcome Measure:
15 Unknown  Thyroid Hormone Dose Adjustment in PREGNANCY
Conditions: PREGNANCY;   Hypothyroidism
Interventions: Drug: Anticipatory dose increase of levothyroxine;   Drug: levothyroxine
Outcome Measures: proportion of patients in each treatment arm euthyroid through gestation;   the proportion of patients in each arm who required, and the gestation week at which, levothyroxine dose adjustments (either increased or decreased) occurred to maintain a euthyroid state;   Determination of the necessary frequency of serum evaluation of TSH during the first half of gestation.
16 Recruiting The Savella PREGNANCY Registry
Condition: Fibromyalgia
Outcome Measures: The primary objective is to estimate the prevalence of major congenital anomalies among off-springs of women exposed to Savella during PREGNANCY.;   Estimate the prevalence of spontaneous abortions, stillbirths, induced abortions, minor congenital anomalies, and adverse PREGNANCY outcomes.
17 Recruiting Trial of Acupuncture Pelvic and Low Back Pain in PREGNANCY (Medical and Economical Assessment)
Condition: Disorder of PREGNANCY
Interventions: Other: acupuncture;   Other: usual care
Outcome Measures: Number and % of days during PREGNANCY with maximum pain ≤ 4/10.;   Mean Oswestry disability score;   Number and % of days with maximum pain ≤ 4/10.;   direct and indirect costs
18 Not yet recruiting Boostrix® PREGNANCY Registry
Condition: Pertussis
Intervention: Other: Data collection
Outcome Measure: Occurrence of any abnormal PREGNANCY outcomes in women intentionally or unintentionally vaccinated with Boostrix during PREGNANCY or within 28 days preceding conception
19 Unknown  Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous PREGNANCY
Conditions: PREGNANCY;   Vulvovaginitis;   Uterine Cervicitis;   PREGNANCY Outcome
Intervention: Other: Active search of lower genital tract infections
Outcome Measure: Track pregnant women priority for the exams that allow the etiologic diagnosis of lower genital tract infections.
20 Not yet recruiting A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent PREGNANCY Loss (RPL)
Conditions: Recurrent PREGNANCY Loss;   Recurrent Miscarriage
Interventions: Drug: NT100;   Drug: Placebo
Outcome Measures: Clinical PREGNANCY;   Live birth;   Clinical PREGNANCY;   Spontaneous PREGNANCY loss;   Stillbirth;   Subjects with adverse events and serious adverse events;   Changes in clinical laboratory parameters following study drug exposure